Article: NEW JERSEY ENTERS MULTI-STATE SETTLEMENT WITH MERCK, SCHERING-PLOUGH, JOINT VENTURE ON VYTORIN

TRENTON, N.J., July 15 -- The New Jersey Attorney General issued the following news release:

Attorney General Anne Milgram announced today that New Jersey has entered into a multi-state settlement with Merck & Co. Inc, Schering-Plough Corporation, and a joint venture of the two companies, MSP Singapore Company, LLC, resolving an investigation into a lengthy delay by the companies in issuing negative results from a clinical trial of their cholesterol-lowering drug Vytorin.

The clinical trial was called Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression, or ENHANCE.

Under terms of the settlement, Merck & Co., Schering-Plough and MSP Singapore have ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!